See the DrugPatentWatch profile for Triesence
What is Triesence?
Triesence is a medicine used in eye treatment for people with macular edema, a condition where fluid builds up in the central part of the retina and can reduce vision. It is given as an intravitreal implant (injected into the eye) under ophthalmologist care.
What condition is Triesence used for?
The main use of Triesence is for macular edema related to:
- Uveitis (inflammation inside the eye)
- Other causes of macular swelling depending on the treating clinician’s assessment
How is Triesence given?
Triesence is placed inside the eye by an ophthalmologist as an implant/injection into the vitreous cavity. The schedule and whether re-treatment is needed depend on the underlying cause of the macular edema and the person’s response.
What are the main risks and side effects patients ask about?
Because Triesence contains a corticosteroid, known eye-related risks include:
- Increased eye pressure (intraocular pressure)
- Cataract development or worsening (in people who still have natural lenses)
- Eye inflammation or infection risks associated with any intravitreal procedure
Patients are typically monitored for pressure changes and visual outcomes after treatment.
Is Triesence the same as other steroids used for eye swelling?
Triesence is part of the corticosteroid treatment category for macular edema, but it is distinguished by its formulation and delivery method (an intravitreal implant). Other steroid options exist, and the choice often depends on the cause of the edema, prior treatments, and risk factors such as steroid-related eye pressure rise.
How long does Triesence last?
The duration of effect varies by patient and condition, but the treatment is designed to provide steroid exposure over time from within the eye rather than as a short-lived injection. Your eye specialist decides when (or whether) repeat treatment is needed based on how the retina responds.
Does Triesence work if anti-VEGF treatments fail?
In many care pathways, anti-VEGF injections are first-line for certain types of macular edema. For inflammatory causes (and some cases where anti-VEGF response is limited), corticosteroid implants like Triesence can be considered based on clinical judgment and patient risk profile.
What monitoring happens after a Triesence injection?
After treatment, clinicians generally monitor:
- Visual acuity
- Retinal thickness/fluid status (often with OCT imaging)
- Eye pressure and signs of cataract progression (if applicable)
- Any signs of complications from the injection
Which exact Triesence details are you looking for?
“Triesence” can be discussed from a few angles (uses, dosing schedule, side effects, comparisons, or how it fits into treatment pathways). Tell me which one you need—e.g., “side effects,” “how often it’s repeated,” “who it’s for,” or “how it compares with Ozurdex/anti-VEGF”—and I’ll tailor the answer.